Mesa Laboratories, Inc. (MLAB) Surges to Record High at $212.65 on Jun, 29

June 29, 2018 - By Carey Conley

Mesa Laboratories, Inc. (NASDAQ:MLAB) Corporate Logo

Big Money Sentiment decreased to 1.15 in Q1 2018. It has change of 0.06, from 2017Q4’s 1.21. The ratio dived due to Mesa Laboratories, Inc. positioning: 8 sold and 25 reduced. 9 funds amassed stakes and 29 increased stakes. Investors holded 2.66 million in 2017Q4 but now own 2.68 million shares or 1.10% more.
654 are held by Jpmorgan Chase. Invesco Limited reported 2,757 shs. The Florida-based Raymond James Fincl Svcs Advsr Inc has invested 0.01% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Navellier Associate accumulated 1,786 shs or 0.04% of the stock. Voya Invest Mngmt Lc reported 1,545 shs stake. Bank & Trust Of Montreal Can accumulated 17 shs. Us Bankshares De reported 0% stake. 6,807 were reported by Stifel Fincl. Iowa-based Cambridge Research has invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Sit Invest Incorporated holds 0.02% or 4,650 shs in its capital. Geode Mgmt Limited has 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB). Comerica Commercial Bank stated it has 0.01% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Ameriprise Fin Incorporated has invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Bahl Gaynor Incorporated holds 13,172 shs. Natl Bank Of America Corporation De has invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB).

Mesa Laboratories, Inc. registered $4.88 million net activity with 0 insider purchases and 5 selling transactions since February 15, 2018. CAMPBELL H STUART sold 989 shs worth $189,065. Dwyer Robert V sold $1.05M worth of stock.

Today, Jun, 29 Mesa Laboratories, Inc. (NASDAQ:MLAB) with $212.65 price per share, hit all time high. $231.79 target or 9.00 % above is our PT. This stock pattern was announced by Barchart.com. Mesa Laboratories, Inc. (NASDAQ:MLAB) has $809.87M market cap. The valuation of NASDAQ:MLAB can change by $72.89M if our $231.79 target is hit.

MLAB hit $212.65 during the last trading session after $8.7 change.Mesa Laboratories, Inc. has volume of 19,019 shares. Since June 29, 2017 MLAB has risen 5.34% and is uptrending. MLAB underperformed the S&P500 by 7.23%.

There’s an important Mesa Laboratories, Inc. (NASDAQ:MLAB) news published by Nasdaq.com. It’s an article titled: “Mesa Labs Reports Record Revenues and Adjusted Operating Income for the Fourth Quarter and Fiscal Year 2018” on June 05, 2018.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products.The company has $809.87 million market cap. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.Last it reported negative earnings. This segment's products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.